Navigation Links
Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches
Date:5/22/2013

New York (PRWEB) May 22, 2013

The Conference Forum announced the launch of the 3rd Annual Disruptive Innovations to Advance Clinical Trials conference taking place on September 19-20 at the Fairmont Copley Plaza Hotel in Boston, MA.

Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, Medimmune, Genzyme, Janssen Pharmaceuticals and more share bold approaches to reduce expensive infrastructure, engage patients and generate credible clinical data.

“Disruptive innovation needs to be big, or novel, or it must change the very nature of how we do clinical development,” explains Dr Andreas Koester, VP, Clinical Trial Innovation & External Alliances, Janssen Pharmaceutical, one of the event’s co-chairs.

New sessions for the 2013 event include:
*How Not to Do a Traditional Clinical Trial
*Alternative Clinical Settings: The Walgreens-Novartis Collaboration
*Keynote Fireside Chat with Google Ventures on Disruption in Drug development, New Approaches with Mobile Technologies and the Big Data Revolution
*An Interview Series with Disruptive Thinkers from Medimmune, VA Boston Healthcare and the Center for Connected Health

“We are particularly excited to welcome Zen Chu, Faculty Director and Entrepreneur-In-Residence from MIT to present the results of a hackathon on the topic of clinical trials, and Dr John J. Whyte, Chief Medical Expert & VP, Health and Medical Education at Discovery Channel for the interview series,” explains Valerie Bowling, Event Director.

The event expects to attract over 300 disruptive thinkers from pharmaceutical, biotech and technology companies seeking disruptive ideas to change the pace of clinical trials.

For more information, visit http://www.theconferenceforum.org.

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10750006.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. uniQure Named to MIT Technology Reviews 2013 50 Disruptive Companies List Recognizing Worlds Most Innovative Companies
2. BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
3. DuPont Celebrates Scientific Innovation by Recognizing Young Professors
4. SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions
5. Kitware to Enhance the Visualization Toolkit (VTK) to Accelerate Community-Driven Medical Innovation
6. Lorain County Community College, Austen BioInnovation Institute Join to Advance Medical Technologies
7. Global CEO Initiative on Alzheimers Disease (CEOi) Commits Industry to Innovation and Leadership in the Global Fight Against Alzheimers and Dementia
8. Nominations Open for the Inaugural Harrington Prize for Innovation in Medicine
9. Tata Partners with Tel Aviv University to Fund Leading Edge Innovations for Accelerated Commercialization
10. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
11. Selexis SA to Speak on Next Generation Innovations for Secretion Bottlenecks at the 2013 Protein Engineering Summit (PEGS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD), and ... have partnered to deliver exclusive content to ReachMD learners. , The partnership, ...
(Date:3/29/2017)... year,s petition to the White House signed by 120,000 ... generate awareness on the importance of new organic medicines and nutritional ... place. ... this month Health Advance (OTC PINK: HADV ), ... announced its endeavors on this generally recognized as safe ...
(Date:3/29/2017)... , March 29, 2017  Applied BioMath ... mechanistic modeling to drug research and development, ... with Zymeworks Inc. for quantitative systems pharmacology ... intended for the treatment of cancer. ... previously for GLP toxicology studies and first-in-human ...
(Date:3/29/2017)... Canaan, CT (PRWEB) , ... March 29, 2017 , ... ... antibiotics and hormones in the world’s food supply through enhancement of the gut microbiota, ... the round included Connecticut Innovations , New York-based Sustainable Income Capital Management, LLC ...
Breaking Biology Technology:
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):